| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/02/2006 | EP1503789A4 Vascularization enhanced graft constructs |
| 08/02/2006 | EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders |
| 08/02/2006 | EP1450843B1 Use of thymulin-like peptides for making pain-relieving medicines |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1397154B1 Abin-mediated hepatitis protection |
| 08/02/2006 | EP1345694B1 A method for the manufacture of compositions containing low concentrations of salts |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |
| 08/02/2006 | EP1056878B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |
| 08/02/2006 | EP0996629B1 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 08/02/2006 | EP0979243B1 Activation of peptides |
| 08/02/2006 | EP0939621B1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0832250B1 Mutant alpha-amylase |
| 08/02/2006 | EP0696206B1 Adenoviruses having modified fiber proteins |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |
| 08/02/2006 | CN1813062A Bacteriophages bacteriolysin |
| 08/02/2006 | CN1812998A Secreted protein family |
| 08/02/2006 | CN1812997A Pharmaceutical composition |
| 08/02/2006 | CN1812808A Stabilized pharmaceutical peptide compositions |
| 08/02/2006 | CN1812807A Stabilized pharmaceutical peptide compositions |
| 08/02/2006 | CN1812806A Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 08/02/2006 | CN1812805A Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 08/02/2006 | CN1812804A Selective r-cadherin antagonist and methods |
| 08/02/2006 | CN1812803A Human mast cell-expressed membrane protein |
| 08/02/2006 | CN1812799A Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 08/02/2006 | CN1812776A Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 08/02/2006 | CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/02/2006 | CN1810836A Human proinsulin-KGD chimeric peptide as new recombinat antithrombotic with thrombocyte GP-IIb-IIIa receptor specificity |
| 08/02/2006 | CN1810833A Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 08/02/2006 | CN1810832A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 08/02/2006 | CN1810831A Arf6 activator protein and its coding gene and application |
| 08/02/2006 | CN1810830A HIV-1 yesisting polypeptide C22, its coding sequence and prepn process |
| 08/02/2006 | CN1810292A Protein purification by ion exchange chromatography |
| 08/02/2006 | CN1810282A Soft black bone chicken and white phoenix capsule and its prepn process and quality control method |
| 08/02/2006 | CN1810258A Compound hemostatic originated from venom |
| 08/02/2006 | CN1267555C Sea anemone neurotoxin gene Sr4 and application thereof |
| 08/02/2006 | CN1267554C Sea anemone neurotoxin gene Sr5 and application thereof |
| 08/02/2006 | CN1267553C Haemophilus transferrin receptor genes |
| 08/02/2006 | CN1267552C Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 08/02/2006 | CN1267551C Expression of recombinant mature lysostaphin |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267453C Human erythropoietin Fc fusion protein with raised bioactivity |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267450C New tumor necrosin mutein and its preparation and application |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267152C Polythylene glycol-interferon alpha foreeze dried preparation |
| 08/02/2006 | CN1267151C Alkaline fibroblast growth factor pellicle and its production method |
| 08/02/2006 | CN1267150C Eye drops |
| 08/02/2006 | CN1267149C Composition and method to improve neural outcome |
| 08/02/2006 | CN1267148C Use of GnRH antagonists in prevention of diabetes by administration |
| 08/02/2006 | CN1267024C Tryptophan source from plants and uses therefor |
| 08/01/2006 | USRE39219 Isolated Dna |
| 08/01/2006 | US7084267 for the regulation of telomerase RNA genes, including the Sp family of transcription factors |
| 08/01/2006 | US7084262 Analysis and separation of platelet-derived growth factor proteins |
| 08/01/2006 | US7084261 formed by reacting a polypeptide with a capped N-(formylalkyl)polyoxyalkylenealkamide, used for inhibiting HIV infection |
| 08/01/2006 | US7084258 Antibodies against the PRO862 polypeptides |
| 08/01/2006 | US7084257 Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
| 08/01/2006 | US7084256 Plant extract; folded polypeptide |
| 08/01/2006 | US7084254 Ti-4 protein derived from Triatoma infestans exhibiting activity to inhibit platelet aggregation |
| 08/01/2006 | US7084253 Protease-activated receptor PAR4 (ZCHEMR2) |
| 08/01/2006 | US7084250 asymmetric hydrogenation of 2-[2-acetylamino-3-(4-cyanophenyl)acryloylamino]-2-cyclohexylacetic acid and conversion of the cyano group into the amidine, or a salt thereof, with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt; claimed intermediates |
| 08/01/2006 | US7084248 Weak-base amphiphilic delivery peptides for delivering large polar substances via indirect endocytosis-mediated delivery; predominantly non-ionic at neutral pH, bind but do not permeabilize cell membranes until after endocytosis and acidification |
| 08/01/2006 | US7084247 Identification of self and non-self antigens implicated in autoimmune diseases |
| 08/01/2006 | US7084246 Epidermal growth factor agonists |
| 08/01/2006 | US7084245 Peptides that bind to the erythropoietin receptor |
| 08/01/2006 | US7084244 Formed by means of bridging groups attached via the alpha nitrogens of amino acid derivatives to provide novel non-peptidic linkages; backbone cyclized bradykinin antagonists having biological activity |
| 08/01/2006 | US7084243 Glucagon-like peptide-1 analogs |
| 08/01/2006 | US7084242 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 08/01/2006 | US7084241 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084239 stimulates cancer antigen specific cytotoxic T lymphocytes; useful in cancer diagnostics and immunotherapeutics including a cancer vaccine. |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084134 Such as (6R,20aS)-16-chloro-6-cyclohexyl-2,3,6,7,9,10,18,19-octahydro-1H- pyrrolo-(1,2-j)(1,4,7,10,13)-benzoxatetraazacyclohexadecine -5,8,11,20(12H,20aH)-tetrone |
| 08/01/2006 | US7084130 Solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. |
| 08/01/2006 | US7084126 Methods and compositions for enhancing cellular function through protection of tissue components |
| 08/01/2006 | US7084121 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 08/01/2006 | US7084120 Prodrugs of DP IV-inhibitors |
| 08/01/2006 | US7084119 Fibroblast growth factor peptide fragments having deletions in the amino acid sequences, conjugates with ricin, diphtheria or saporin, and carrier mixtures, used as wound heling agents or antiproliferative agents |
| 08/01/2006 | US7084118 Combination treatment with t-PA variant and low molecular weight heparin |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084116 Overactive bladder; oral administering a conotoxin |
| 08/01/2006 | US7084114 Mixtures of insulin drug-oligomer comprising polyalkylene glycol |
| 08/01/2006 | US7084113 comprises a successfully elucidated crystal structure of a glycoprotein-binding protein originating from snake venom |
| 08/01/2006 | US7084112 Activated polyethylene glycol compounds |
| 08/01/2006 | US7084111 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity |
| 08/01/2006 | US7084110 Anticarcinogenic agents for treating cancer; pentapeptides, hexapeptides, heptapeptides, oligopeptides |
| 08/01/2006 | US7084109 FVIIa antagonists |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7084106 Reducing amyloid plaque deposits in brain; antiinflammatory agents |
| 08/01/2006 | US7084105 Activating adenine triphosphate independent cytolytic modulator for use in the treatment of infection and cancer; generate nutrient broth, propagate microorganisms, allow microorganism to secrete protein, recover protein |
| 08/01/2006 | US7083983 Inhibitors of the interaction between P53 and MDM2 |
| 08/01/2006 | US7083970 Comprises ribonuclease barnase marker gene; recombination/genetic engineering; libraries; drug resistance |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083964 Using chromatographic columns comprising styrene/divinyl-benzene and/or ceramic hydroxylapatite base for isolation of clostridial catalytic polypeptides |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |